MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Not Applicable
Completed
Conditions
Lung Cancer
Interventions
Procedure: Endobronchial Ultrasound
Procedure: Mediastinoscopy
First Posted Date
2007-11-16
Last Posted Date
2018-03-29
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
53
Registration Number
NCT00559611
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Haelan and Nutrition in Cancer Patients

Phase 2
Terminated
Conditions
Cachexia
Weight Loss
Anorexia
Interventions
Drug: Haelan
First Posted Date
2007-11-15
Last Posted Date
2016-05-13
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
6
Registration Number
NCT00558558
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Role of Methadone As Co-Opioid Analgesic

Phase 2
Terminated
Conditions
Pain
Interventions
First Posted Date
2007-11-15
Last Posted Date
2016-04-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
5
Registration Number
NCT00558870
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Meditation and Cognitive Function in Women With Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Behavioral: Tibetan Meditation Program
Behavioral: No Meditation
First Posted Date
2007-11-09
Last Posted Date
2022-08-30
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
47
Registration Number
NCT00556218
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

Phase 1
Terminated
Conditions
Glioblastoma Multiforme
Anaplastic Glioma
Interventions
First Posted Date
2007-11-08
Last Posted Date
2024-08-22
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
55
Registration Number
NCT00555399
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Trial of PBI-05204 in Advanced Cancer Patients

Phase 1
Completed
Conditions
Solid Tumors
Interventions
Drug: PBI-05204
First Posted Date
2007-11-06
Last Posted Date
2016-02-19
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
58
Registration Number
NCT00554268
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Phase 3
Completed
Conditions
Chemotherapy-induced Nausea and Vomiting
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
First Posted Date
2007-11-04
Last Posted Date
2020-10-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
62
Registration Number
NCT00553059
Locations
🇺🇸

University of Texas M.D. Anderson, Houston, Texas, United States

🇺🇸

CCOP - Greenville, Greenville, South Carolina, United States

🇺🇸

Cancer Research for the Ozarks, Springfield, Missouri, United States

and more 1 locations

Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy

Phase 3
Completed
Conditions
Brain Cancer
Interventions
Other: Observation
Procedure: Whole Brain Radiation Therapy
Behavioral: Questionnaire
First Posted Date
2007-10-24
Last Posted Date
2023-06-07
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
152
Registration Number
NCT00548756
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer

Phase 1
Completed
Conditions
Rectal Cancer
Interventions
Drug: Bevacizumab
Drug: Capecitabine
Drug: Erlotinib
Radiation: Radiation Therapy
Procedure: Surgery
First Posted Date
2007-10-15
Last Posted Date
2015-02-26
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
19
Registration Number
NCT00543842
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Bevacizumab in Multiple Phase I Combinations

First Posted Date
2007-10-15
Last Posted Date
2020-06-30
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
343
Registration Number
NCT00543504
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath